Implantable cardioverter defibrillator therapy in chronic kidney disease: A meta-analysis

Europace

Volumn 11, Issue 11, 2009, Pages 1469-1475

  Korantzopoulos, Panagiotis ^a   Liu, Tong ^b   Li, Lijian ^b   Goudevenos, John A ^a   Li, Guangping ^b  

^a UNIVERSITY OF IOANNINA   (Greece)

^b SECOND HOSPITAL OF TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Arrhythmias; Chronic kidney disease; Heart failure; Implantable cardioverter defibrillators; Mortality; Renal disease; Renal failure

Indexed keywords

ARTICLE; CARDIOVERSION; CHRONIC KIDNEY DISEASE; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; DEFIBRILLATION; DEFIBRILLATOR; GLOMERULUS FILTRATION RATE; HEART ARRHYTHMIA; HEART FAILURE; HUMAN; IMPLANTATION; KIDNEY FUNCTION; META ANALYSIS; MORTALITY; PRIORITY JOURNAL; RISK ASSESSMENT; SYSTEMATIC REVIEW; TREATMENT INDICATION; TREATMENT OUTCOME;

ARRHYTHMIAS, CARDIAC; COMORBIDITY; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; FEMALE; HEART FAILURE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 71049138054     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eup282     Document Type: Article

References (40)

1. Exner DV. Clinical trials of defibrillator therapy. In Ellenbogen KA, Kay GN, Lau CP, Wilkoff BL (eds). Clinical Cardiac Pacing, Defibrillation, and Resynchronization Therapy. 3rd ed. Philadelphia: Saunders-Elsevier; 2007.
2. Myerburg RJ. Implantable cardioverter-defibrillators after myocardial infarction. N Engl J Med 2008;359:2245-2253
3. Tung R, Zimetbaum P, Josephson ME. A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death. J Am Coll Cardiol 2008;52:1111-1121
4. Parkash R, Stevenson WG, Epstein LM, Maisel WH. Predicting early mortality after implantable defibrillator implantation: A clinical risk score for optimal patient selection. Am Heart J 2006;151:397-403.
5. Bruch C, Bruch C, Sindermann J, Breithardt G, Gradaus R. Prevalence and prognostic impact of comorbidities in heart failure patients with implantable cardioverter defibrillator. Europace 2007;9:681-686
6. Cygankiewicz I, Gillespie J, Zareba W, Brown MW, Goldenberg I, Klein H et al., MADIT II Investigators. Predictors of long-term mortality in Multicenter Automatic Defibrillator Implantation Trial II (MADIT II) patients with implantable cardioverter-defibrillators. Heart Rhythm 2009;6:468-473
7. Saran AM, DuBose TD Jr. Cardiovascular disease in chronic kidney disease. Ther Adv Cardiovasc Dis 2008;2:425-434
8. Goldenberg I, Moss AJ. Implantable cardioverter defibrillator efficacy and chronic kidney disease: Competing risks of arrhythmic and nonarrhythmic mortality. J Cardiovasc Electrophysiol 2008;19:1281-1283
9. Herzog CA, Mangrum JM, Passman R. Sudden cardiac death and dialysis patients. Semin Dial 2008;21:300-307
10. Coca SG, Krumholz HM, Garg AX, Parikh CR. Underrepresentation of renal disease in randomized controlled trials of cardiovascular disease. JAMA 2006; 296:1377-1384
11. Amin MS, Fox AD, Kalahasty G, Shepard RK, Wood MA, Ellenbogen KA. Benefit of primary prevention implantable cardioverter-defibrillators in the setting of chronic kidney disease: A decision model analysis. J Cardiovasc Electrophysiol 2008;19:1275-1280
12. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D et al. Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000;283:2008-2012
13. Harris RP, Helfand M, Woolf SH, Lohr KN, Mulrow CD, Teutsch SM et al., Methods Work Group, Third US Preventive Services Task Force. Current methods of the US Preventive Services Task Force: A review of the process. Am J Prev Med 2001;20:21-35.
14. Levine M, Walter S, Lee H, Haines T, Holbrook A, Moyer V. Users' guides to the medical literature. IV. How to use an article about harm. Evidence-Based Medicine Working Group. JAMA 1994;271:1615-1619 (Pubitemid 24155624)
15. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999;130:461-470
16. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002;21:1539-1558
17. Goldenberg I, Moss AJ, McNitt S, Zareba W, Andrews ML, Hall WJ et al., Multicenter Automatic Defibrillator Implantation Trial-II Investigators. Relations among renal function, risk of sudden cardiac death, and benefit of the implanted cardiac defibrillator in patients with ischemic left ventricular dysfunction. Am J Cardiol 2006;98:485-490
18. Eckart RE, Gula LJ, Reynolds MR, Shry EA, Maisel WH. Mortality following defi- brillator implantation in patients with renal insufficiency. J Cardiovasc Electrophysiol 2006;17:940-943
19. Lee DS, Tu JV, Austin PC, Dorian P, Yee R, Chong A et al. Effect of cardiac and noncardiac conditions on survival after defibrillator implantation. J Am Coll Cardiol 2007;49:2408-2415
20. Khan E, Voudouris A, Shorofsky SR, Peters RW. Inappropriate ICD discharges due to 'triple counting' during normal sinus rhythm. J Interv Card Electrophysiol 2006;17:153-155
21. Wase A, Basit A, Nazir R et al. Impact of chronic kidney disease upon survival among implantable cardioverter-defibrillator recipients. J Interv Card Electrophysiol 2004;11:199-204.
22. Robin J, Weinberg K, Tiongson J, Carnethon M, Reddy M, Ciaccio C et al. Renal dialysis as a risk factor for appropriate therapies and mortality in implantable cardioverter-defibrillator recipients. Heart Rhythm 2006;3:1196-1201
23. Koplan BA, Epstein LM, Albert CM, Stevenson WG. Survival in octogenarians receiving implantable defibrillators. Am Heart J 2006;152:714-719
24. Cuculich PS, Sanchez JM, Kerzner R, Greenberg SL, Sengupta J, Chen J et al. Poor prognosis for patients with chronic kidney disease despite ICD therapy for the primary prevention of sudden death. Pacing Clin Electrophysiol 2007;30:207-213
25. Chen-Scarabelli C, Scarabelli TM. Chronic renal insufficiency is an independent predictor of mortality in implantable cardioverter-defibrillator recipients. Pacing Clin Electrophysiol 2007;30:371-376
26. Turakhia MP, Varosy PD, Lee K, Tseng ZH, Lee R, Badhwar N et al. Impact of renal function on survival in patients with implantable cardioverter- defibrillators. Pacing Clin Electrophysiol 2007;30:377-384
27. Hreybe H, Razak E, Saba S. Effect of end-stage renal failure and hemodialysis on mortality rates in implantable cardioverter-defibrillator recipients. Pacing Clin Electrophysiol 2007;30:1091-1095
28. Levy R, DellaValle A, Atav AS, ur Rehman A, Sklar AH, Stamato NJ. The relationship between glomerular filtration rate and survival in patients treated with an implantable cardioverter defibrillator. Clin Cardiol 2008;31:265-269
29. Schefer T, Wolber T, Binggeli C, Holzmeister J, Brunckhorst C, Duru F. Longterm predictors of mortality in ICD patients with non-ischaemic cardiac disease: Impact of renal function. Europace 2008;10:1052-1059
30. Sakhuja R, Keebler M, Lai TS, McLaughlin Gavin C, Thakur R, Bhatt DL. Meta-analysis of mortality in dialysis patients with an implantable cardioverter defibrillator. Am J Cardiol 2009;103:735-741
31. Remppis A, Ritz E. Cardiac problems in the dialysis patient: Beyond coronary disease. Semin Dial 2008;21:319-325
32. Chonchol M, Goldenberg I, Moss AJ, McNitt S, Cheung AK. Risk factors for sudden cardiac death in patients with chronic renal insufficiency and left ventricular dysfunction. Am J Nephrol 2007;27:7-14.
33. Herzog CA, Li S, Weinhandl ED, Strief JW, Collins AJ, Gilbertson DT. Survival of dialysis patients after cardiac arrest and the impact of implantable cardioverter defibrillators. Kidney Int 2005;68:818-825
34. Dries DL, Exner DV, Domanski MJ, Greenberg B, Stevenson LW. The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction. J Am Coll Cardiol 2000;35:681-689
35. Joles JA, Koomans HA. Causes and consequences of increased sympathetic activity in renal disease. Hypertension 2004;43:699-706.
36. Bloom H, Heeke B, Leon A, Mera F, Delurgio D, Beshai J et al. Renal insufficiency and the risk of infection from pacemaker or defibrillator surgery. Pacing Clin Electrophysiol 2006;29:142-145
37. Lekkerkerker JC, van Nieuwkoop C, Trines SA, van der Bom JG, Bernards A, van de Velde ET et al. Risk factors and time delay associated with cardiac device infections: Leiden device registry. Heart 2009;95:715-720
38. Dasgupta A, Montalvo J, Medendorp S, Lloyd-Jones DM, Ghossein C, Goldberger J et al. Increased complication rates of cardiac rhythm management devices in ESRD patients. Am J Kidney Dis 2007;49:656-663
39. Daubert JP, Zareba W, Cannom DS, McNitt S, Rosero SZ, Wang P et al., MADIT II Investigators. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: Frequency, mechanisms, predictors, and survival impact. J Am Coll Cardiol 2008;51:1357-1365
40. Korantzopoulos P, Kokkoris S, Liu T, Protopsaltis I, Li G, Goudevenos JA. Atrial fibrillation in end-stage renal disease. Pacing Clin Electrophysiol 2007;30:1391-1397